Author Archives: Scalper1

Building A Hedged Portfolio Around A Position In Novo Nordisk

Summary One of the more appealing stocks to consider as part of a concentrated portfolio is Novo Nordisk, the leading diabetes care and biopharmaceutical company. We review some reasons why Novo Nordisk is appealing, and discuss how an investor can include it in a concentrated portfolio, while limiting his risk and maximizing expected return. We recap the method, show how you can build a concentrated hedged portfolio yourself, and present a sample hedged portfolio built around Novo Nordisk. The sample portfolio is designed for someone with $80,000 to invest, who wants to limit his risk to a drawdown of no more than 18%. The sample portfolio has a negative hedging cost. The Number One Stock In the World Part of the attraction of Seeking Alpha articles is often the comments they generate. In the latest installment of his series on his top investments (“The #1 Stock In the World, Part II”), hedge fund manager and Seeking Alpha contributor Chris DeMuth, Jr. named Ocean Shore (OCSH) as his current favorite. In a comment on that article, his fellow Seeking Alpha contributor Harm Elderman offered an intriguing alternative selection for that title, Novo Nordisk (NYSE: NVO ), and added: “It’s been my largest share of my portfolio for over 8 years and every year it’s been an incredible cash cow (as it has been all the years before and will be in the future). Seriously, take a look. This firm has bent some stock market rules (in my view) over the last 25 years in regards of risk/reward profile.” The Appeal of NVO Although DeMuth aims to “sift the world”, it’s understandable that he can’t cover every promising stock. At the same time, a closer look at NVO illuminates the appeal it has had for Elderman and many other investors. (click to enlarge) Riding a global mega trend Although Novo Nordisk is active in other areas such as growth hormone treatments, it remains a leading manufacturer of diabetes medications, such as the NovoLog FlexPen prefilled insulin syringe, pictured above. Diabetes is a global epidemic: according to the World Health Organizaton, as of 2014, 9% of the world’s adult population was estimated to suffer from the disease. The International Diabetes Foundation’s Diabetes Atlas estimates the total number of diabetes cases globally is 387 million. By way of comparison, the WHO estimates there are 37 million patients in the world living with HIV. The scale of the diabetes epidemic, and Novo Nordisk’s 90-year history in diabetes treatment, provides some context to the remarkable long-term chart of the company’s shares: (click to enlarge) Not only does the scale of diabetes dwarf that of HIV and AIDS (fewer than half of those infected with HIV currently suffer from AIDS), but the epidemic is expected to grow considerably over the next two decades. The Diabetes Atlas estimates 592 million people will be living with the disease in 2035. Selected Fundamentals Novo Nordisk shares aren’t cheap on an absolute basis – according to Fidelity’s data, the current PEG ratio for the stock (using 5-year earnings growth projections) is 1.97, while a PEG ratio of 2 or greater is often considered to be high. However, the average PEG ratio for the pharmaceutical industry is 4.13. Particularly striking, though, are the company’s returns on sales, equity, assets, and investment, as shown below (image via Fidelity). (click to enlarge) Equity Summary Score Fidelity aggregates opinions on stocks from multiple research shops and weights each opinion by the historical accuracy of the researchers. It then consolidates that data into an “equity summary score”, on a scale from 1 to 10, with 10 being the most bullish. As the image below shows, the current equity summary score for NVO is very bullish. Building a Hedged Portfolio Around an NVO Position Given the appeal of NVO, why consider hedging it? For two reasons: Any stock may be subject to unpredictable, idiosyncratic risk. For a recent example , consider the emissions scandal at Volkswagen ( OTCQX:VLKAY ). All stocks are subject to market risk: in the event of a major market correction, all stocks are likely to plummet. You could simply buy and hedge NVO, and we’ll show a sample hedge for it below, but the benefits of the hedged portfolio method are that it can lower your overall hedging cost and let you maximize your expected return. So, we’ll use NVO as starting point and show how you can build a hedged portfolio around it for an investor who is unwilling to risk a drawdown of more than 18%, and has $80,000 that he wants to invest. First, though, let’s address the issue of risk tolerance, and how it affects potential return. Risk Tolerance and Potential Return All else equal, with a hedged portfolio, the greater an investor’s risk tolerance, the greater the maximum drawdown he is willing to risk (his “threshold”, in our terminology) and the higher his potential return will be. So, we should expect that an investor who is willing to risk a 28% decline will have a chance at higher potential returns than one who is only willing to risk an 8% drawdown. In our example, we’ll be splitting the difference and using an 18% threshold. Constructing A Hedged Portfolio We’ll outline the process here briefly, and then explain how you can implement it yourself. Finally, we’ll present an example of a hedged portfolio that was constructed this way with an automated tool. The process, in broad strokes, is this: Find securities with promising potential returns (we define potential return as a high-end, bullish estimate of how the security will perform). Find securities that are relatively inexpensive to hedge. Buy a handful of securities that score well on the first two criteria; in other words, buy a handful of securities with high potential returns net of their hedging costs (or, ones with high net potential returns). Hedge them. The potential benefits of this approach are twofold: If you are successful at the first step (finding securities with high potential returns), and you hold a concentrated portfolio of them, your portfolios should generate decent returns over time. If you are hedged, and your return estimates are completely wrong, on occasion – or the market moves against you – your downside will be strictly limited. How to Implement This Approach Finding promising stocks In this case, we’ve got one promising stock already, NVO. To find others, you can use Seeking Alpha Pro , among other sources. To quantify potential returns for these stocks, you can use analysts’ consensus price targets for them, to calculate potential returns in percentage terms. For example, via Nasdaq’s website , the image below shows the sell-side analysts’ consensus 12 month price target for NVO as of October 9th, 2015: Since NVO closed at $54.61 on October 9th, the consensus price target suggests a 16.4% potential return over 12 months. In general, though, you’ll need to use the same time frame for each of your potential return calculations to facilitate comparisons of potential returns, hedging costs, and net potential returns. Our method starts with calculations of six-month potential returns. Finding inexpensive ways to hedge these securities Whatever hedging method you use, for this example, you’d want to make sure that each security is hedged against a greater-than-18% decline over the timeframe covered by your potential return calculations (our method attempts to find optimal static hedges using collars as well as protective puts going out approximately six months). And you’ll need to calculate your cost of hedging as a percentage of position value. Select the securities with highest, or at least positive, net potential returns When starting from a large universe of securities, you’d want to select the ones with the highest potential returns, net of hedging costs, but, at a minimum, you’d want to at least want to exclude any security that has a negative potential return net of hedging costs. It doesn’t make sense to pay X to hedge a stock if you estimate the stock will return

Laclede Group: Aggressive New Management Is Performing

Summary Laclede doubled its enterprise value in two years via acquisitions. Debt and leverage has ballooned, but so has cash flow from operations. I’m not fully sold on recommending the shares for income investors until I see a solid bump in the dividend. The Laclede Group (NYSE: LG ) is a regulated natural gas utility that has begun making waves in the utility industry over the last several years. Through the acquisitions of Missouri Gas Energy from Southern Union in 2013 and Alagasco from Energen (NYSE: EGN ) in 2014, Laclede Group has shifted from a relatively small utility serving just a portion of the Missouri natural gas market to serving millions of customers, holding dominant market positions in both Missouri and Alabama. Shares in the company have rebounded nicely off early September lows and now trade at all-time highs. Are investors putting too much faith in the future of the company, especially given its less-than-stellar service area? Business Environment Utilities can add incremental revenue in two ways. They can either have customers consume more of the commodity, raise rates on current customers, or add new customers. The first method is unlikely, given that U.S. consumers are consuming less electricity per capita now than in prior years. The advent of energy conservation, more efficient appliances, and less household formation has ensured that the trend is going to remain in a slow slide downward outside of freak weather years increasing demand. With that off the table, utilities like Laclede Group could raise prices on consumers. Not going to fly, because as we know these are regulated operations and public utility commissions set the allowed returns. So the third option (influx of new customers) is really the only source and is something completely out of the utility’s control. This is why there is such a focus on market analytics when valuing utilities. Analysts look at all sorts of factors in the company’s service area: unemployment, average wages, past years’ population growth, etc. Sadly for Laclede, there won’t be much to like here. Missouri and Alabama rank average or below average on nearly every metric you could look at. Unemployment, salary averages, labor participation, poverty, etc. are all below average compared to other states. This scares away many investors, and rightly so. Until these states turn the corner and can draw in new inflows of people, Laclede should likely trade at a discount compared to better positioned peers. Operating Results There has been a lot of change for Laclede Group over the past three years. In fiscal 2011, the company switched CEOs to current leader Suzanne Sitherwood, who made quick work of making changes within the company. Within a few short years under her leadership, the company had sold off its propane assets, made $2.2B worth of acquisitions, and driven up profit/operating margins. Acquisition and expansion don’t come for free, however. Long term debt has spiked from $340M in 2011 to over $1.7B today. Net debt/EBITDA has expanded from a low of 2.1x in fiscal 2011 to what should be around 4x in fiscal 2015. While this is a manageable level of debt for a utility, long-time holders of Laclede should be aware that the risk profile has changed dramatically under the new management style. Excluding the impact of the acquisitions on the cash flow statement ($2.2B paid for with approximately two thirds long-term debt, one third stock offering) things actually look pretty good. Cash from operations is set to fly high in 2015, with the business generating more cash in 2015 than in the prior three years combined. Capital expenditures, like is the case for most natural gas utilities, are comparatively low and under control compared to other utilities that operate in power generation. Results here are ideal and indicative of how I want to see a utility being managed in respect to cash in/cash out. Conclusion Ballsy moves aren’t something the utility industry is known for. Laclede has bucked this trend by engaging in acquisitions that doubled its size in just a few short years. There will be growing pains associated with the acquisitions that may impact short-term results, but I think thus far it looks like company management has made the right play and acquired some solid assets that will easily be folded under the Laclede umbrella. I think investors see the potential here, which is why shares have performed so strongly. For income investors considering entering a position, however, I think this is a “show me” story. Historical dividend growth has been lackluster and I think investors considering going long should wait to see what the next dividend increase pans out to be in fiscal 2016, which should be announced over the next few months. A bump in the 5%+ range would show that management is hitting their targets while also being shareholder friendly.

CenterPoint Energy: Be Sure To Understand What You Own

Summary CenterPoint currently yields nearly 5.35% and has $1.2B in cash reserves. Transmission and distribution income – nearly 50% of operating income – is geographically concentrated. It is largely considered to be a utility – however, a quarter of the income is derived from the MLP equity interest, which has been historically volatile. CenterPoint Energy (NYSE: CNP ) is a diversified pseudo-utility with a wide range of operations. The company operates a regulated natural gas utility business, a transmission and distribution arm, and retains ownership of substantial equity interest in Enable Midstream Partners (NYSE: ENBL ). CNP has been a favorite of investors chasing yield, but the shares have had trouble keeping up with the utility index over the past two years. Unfortunately for shareholders, the shares are down 20%, compared to a 20% gain for the broader utilities index. Contrary to what you might think, the dividend has actually been growing measurably the past two years, and the company now yields over 5.49%, well above historical averages. Is there an opportunity here for shareholders for both solid yield and capital appreciation? Business Operations CenterPoint’s strongest business unit in regards to operating income is its electric transmission and distribution business. This segment provides the infrastructure to connect power plants to substations which connect to the retail customer. This is a low-business risk, high-value business. Because the infrastructure is entirely pole/wire assets, there is significantly less regulatory and environmental risk compared to actual power generation. While this is a monopolistic business with very little risk, CenterPoint’s operations do have geographic risk in that the company only owns assets located in and around the House/Galveston metropolitan area. While this area has retained its strong growth even with the fallout of plummeting energy prices, there is no guarantee that this trend will continue. A reversal in the area’s fortune would result in a slowdown in demand for electricity, driving earnings down in this segment. The most stable and consistent business unit is CenterPoint’s intrastate natural gas distribution business. Compared to the transmission and distribution business that is concentrated in one area, this segment provides natural gas to more than three million customers in six states. Like other gas utilities, the company passes along the cost of the gas to customers, so there is little effect of gas price fluctuations on CenterPoint’s profitability aside from revenue numbers. Further cementing operating results, the company has weather normalization and decoupling mechanisms in place to limit the effects of seasonality and variations in customer demand in five of six states. This portion of CenterPoint is extremely well run, and earnings consistently bump up against the maximum allowed rate of return that the public utility commissions have set for the company (authorized return on equity in the 10% range). As mentioned, CenterPoint owns 55.4% of the limited partner units of Enable Midstream Partners, receiving 40% of the distribution rights. Operational control is split 50/50 between CenterPoint and OGE Energy (NYSE: OGE ). The reason for CenterPoint’s underperformance may largely lie with poor results from Enable. Enable’s first half of the year has been poor when compared to the 2014 results ($93M in operating income for Enable in 1H 2015, compared to $138M in 1H 2014). The downside action in Enable may have been overdone. Compared to many midstream companies like Kinder Morgan (NYSE: KMI ), the company is much less levered (2.6x net debt/EBITDA), making it better positioned to handle any long downturn in U.S. energy midstream operations. I think the weak recent share price performance is primarily related to the company’s short public history and heavy insider ownership. With very little track record and such a small percentage of the float open for trading, the shares have been volatile, scaring many retail and institutional investors away. Operating Results (click to enlarge) Revenue can vary widely year to year, especially within the natural gas distribution segment. As an example, revenue grew 40% from 2012 to 2014 ($959M), but operating income only grew 26% ($60M). This can cause operating margin decreases through no fault of the company as these operating margins decrease as the fixed cost of the natural gas being provided rises. Meanwhile, further putting pressure on operating margins has been a steady increase in operations and maintenance costs within the electric transmission and distribution segment. Between 2012 and 2014, revenue grew 12%. Regrettably, operations and maintenance costs grew 32%. While its maintenance capital expenditures will be recovered as part of capital plans eventually, these recoveries may not be as timely as investors might expect. (click to enlarge) 2014 was a concerning time for the company from a cash flow perspective. Cash from operations had fallen nearly $500M from 2012 levels, and capital expenditures were up tremendously. CenterPoint had to plug the hole with the $600M in proceeds from long-term debt it had raised late in the year prior. With $6.4B in net debt, the company is only moderately leveraged at 3.2x net debt/EBITDA. However, with CenterPoint keeping $1.2B in cash and cash equivalents on the balance sheet, it is prepared to weather any mild operational issues quite well. Conclusion When investing in CenterPoint, investors need to be aware they aren’t buying a company with 100% regulated utility operations. The higher dividend yield here is likely justified, given the volatility present in the Enable ownership. On the plus side, the natural gas operations are very well run, and the electric transmission business, while experiencing headwinds currently, is also solid. In my opinion, the shares likely trade around their fair value. Investors looking for yield can likely comfortably add some exposure to the company in the $17-18/share range.